I MOVE!+UP: Piloting an Integrated Weight Management Program for Veterans With PTSD

March 15, 2024 updated by: Katherine Hoerster, VA Puget Sound Health Care System
This study seeks to test I MOVE!+UP, which integrates individual evidence-based psychotherapy for PTSD with behavioral weight management among Veterans with a Body Mass Index of at least 30 and meeting criteria for current PTSD. Participants will continue receiving routine primary care and psychiatric care management as indicated, in coordination with the I MOVE!+UP therapist. This study is being conducted to see whether I MOVE!+UP holds promise as a treatment for commonly co-occurring PTSD and high Body Mass Index. Participation will involve attending up to 16 psychotherapy visits that last approximately 1-2 hours over 6 months and attending 2 study assessment visits that last approximately 1-2 hours at enrollment and 6 months. Active participation will take up to approximately 6 months.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Post-traumatic stress disorder (PTSD), prevalent among Veterans, puts Veterans at increased risk for obesity and related conditions. Veterans with PTSD lose less weight in VA's MOVE! weight management program, due to PTSD symptoms that interfere with activity and healthy diet. In addition, many Veterans who receive evidence-based PTSD treatment remain symptomatic. A behavioral weight loss program that augments standard PTSD care and targets PTSD-related weight loss barriers called MOVE!+UP was piloted and iteratively refined among 44 overweight Veterans with PTSD, and is currently being tested in an RCT. However, not all Veterans will participate in group-based treatment and prior work on integrated tobacco cessation with individual psychotherapy was quite impactful, and was particularly well-suited for coordinating augmentative medication management using shared decision-making. As such, we propose to conduct an uncontrolled pilot of an intervention called I MOVE!+UP. It will integrate MOVE!+UP into individual evidence-based psychotherapy (i.e.., Cognitive Processing Therapy) for PTSD for up to 6 months, augmented with evidence-based psychiatric and weight management medication management coordination. If I MOVE!+UP is acceptable, feasible, and proof-of-concept outcomes demonstrate potential benefit to weight and PTSD outcomes, we will apply for large-scale funding to test it in an RCT. I MOVE!+UP integrated behavioral intervention will be led by a psychotherapist (social worker, psychologist, or trainee in those disciplines). Because this care will be delivered within the context of routine mental health care, patients will be offered the opportunity for individualized pharmacotherapy for weight loss and psychiatric symptom management as part of their care plan.

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Washington
      • Seattle, Washington, United States, 98108
        • Recruiting
        • VA Puget Sound Health Care System
        • Contact:
        • Contact:
          • Study Coordinator
          • Phone Number: 206-764-2053

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • - U.S. military Veteran

    • PTSD Diagnosis: standard criteria for PTSD Checklist for DSM-5 (PCL-5): lifetime.
  • - Experience of trauma, a score of ≥33, and meets criteria for the symptom domains.
  • - Body Mass Index (BMI) of ≥ 30 kg/m2.
  • - Willing to participate in all intervention and assessment activities

Exclusion Criteria:

  • - Not fluent in English, severe hearing loss, no phone access.
  • - Current MOVE! participation (at least 2 sessions in the past 3 months.)
  • - Current PTSD psychotherapy participation (at least 2 PE or CPT sessions in the past 3 months.)
  • - Past year bariatric surgery or planning to have bariatric surgery in next 6 months.
  • - Current pregnancy.
  • - Based on clinical judgment, would be unable to participate because of a) acutely exacerbated substance use, mental health, or chronic medical conditions or b) moderate to severe chronic, progressive neurologic conditions such as Dementia.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Pilot study of I MOVE!+UP among Veterans with PTSD and BMI of 30 or greater.
Single arm pilot trial.
An individual psychotherapy that integrates behavioral weight management with evidence-based psychotherapy for PTSD (Cognitive Processing Therapy) for up to 6 months, augmented with evidence-based psychiatric and weight management medication management.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight
Time Frame: change from baseline to 6 months
in person weight taken during research visit
change from baseline to 6 months
PTSD symptoms
Time Frame: change from baseline to 6 months
PCL-5 (self-reported)
change from baseline to 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depression symptoms
Time Frame: change from baseline to 6 months
PhQ-8 (self-reported)
change from baseline to 6 months
Insomnia severity
Time Frame: change from baseline to 6 months
Insomnia severity index (self-reported)
change from baseline to 6 months
Diet quality
Time Frame: change from baseline to 6 months
Starting the Conversation (self-reported)
change from baseline to 6 months
Social support for physical activity and healthy eating
Time Frame: change from baseline to 6 months
Modified based on Sallis et al measure (self-reported)
change from baseline to 6 months
Internalized weight bias
Time Frame: change from baseline to 6 months
Internalized weight bias measure (self-reported)
change from baseline to 6 months
Health-related quality of life
Time Frame: change from baseline to 6 months
Sf-12 (self-reported)
change from baseline to 6 months
Waist circumference
Time Frame: change from baseline to 6 months
In person, taken during research visit
change from baseline to 6 months
Blood pressure (systolic)
Time Frame: change from baseline to 6 months
In person, taken during research visit
change from baseline to 6 months
Blood pressure (diastolic)
Time Frame: change from baseline to 6 months
In person, taken during research visit
change from baseline to 6 months
Total cholesterol
Time Frame: change from baseline to 6 months
In person, bloodwork taken during research visit
change from baseline to 6 months
LDL cholesterol
Time Frame: change from baseline to 6 months
In person, bloodwork taken during research visit
change from baseline to 6 months
HDL cholesterol
Time Frame: change from baseline to 6 months
In person, bloodwork taken during research visit
change from baseline to 6 months
Triglycerides
Time Frame: change from baseline to 6 months
In person, bloodwork taken during research visit
change from baseline to 6 months
HbA1C
Time Frame: change from baseline to 6 months
In person, bloodwork taken during research visit
change from baseline to 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Katherine L Hoerster, PhD, MPH, VA Puget Sound Health Care System

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 12, 2023

Primary Completion (Estimated)

July 1, 2024

Study Completion (Estimated)

September 1, 2024

Study Registration Dates

First Submitted

February 8, 2023

First Submitted That Met QC Criteria

March 2, 2023

First Posted (Actual)

March 6, 2023

Study Record Updates

Last Update Posted (Actual)

March 19, 2024

Last Update Submitted That Met QC Criteria

March 15, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1670114

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on PTSD

Clinical Trials on I MOVE!+UP

3
Subscribe